Sudden cardiac death in users of second-generation antipsychotics

Journal of Clinical Psychiatry

Volumn 70, Issue 12, 2009, Pages 1725-

  Karlsson, John ^a   Wallerstedt, Susanna M ^a   Star, Kristina ^b   Bate, Andrew ^b   Hägg, Staffan ^a,c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA MONITORING CENTRE   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTINDOLE; SULPIRIDE; ZIPRASIDONE; ZOTEPINE;

ADOLESCENT; ADULT; AGED; DATA ANALYSIS; DRUG EFFECT; DRUG SAFETY; FEMALE; HEART DEATH; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUDDEN DEATH;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIPSYCHOTIC AGENTS; DATABASES, FACTUAL; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MALE; SAFETY; WORLD HEALTH ORGANIZATION;

EID: 74549146999     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09l05262     Document Type: Letter

References (11)

1. Sicouri S, Antzelevitch C. Sudden cardiac death secondary to antidepressant and antipsychotic drugs. Expert Opin Drug Saf. 2008;7(2):181-194. PubMed doi:10.1517/14740338.7.2.181
2. Davidson M. Risk of cardiovascular disease and sudden death in schizophrenia. J Clin Psychiatry. 2002;63(suppl 9):5-11. PubMed
3. Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360(3):225-235. doi:10.1056/NEJMoa0806994
4. Lindquist M. VigiBase, the WHO Global ICSR database system: basic facts. Drug Inf J. 2008;49(5):409-419.
5. Bate A, Lindquist M, Orre R, et al. Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs. Eur J Clin Pharmacol. 2002;58(7):483-490. PubMed doi:10.1007/s00228-002-0484-z
6. Coulter DM, Bate A, Meyboom RH, et al. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study. BMJ. 2001;322(7296):1207-1209. PubMed doi:10.1136/bmj.322.7296.1207
7. Edwards IR, Bate A, Lindquist M. Abacavir and increased risk of myocardial infarction [letter]. Lancet. 2008;372(9641):805. doi:10.1016/S0140-6736(08)61333-1
8. Torsades list, possible torsades list, and conditional torsades list. Arizona CERT Web site. http://www.azcert.org/medical-pros/drug-lists/bycategory. cfm. Accessed October 27, 2009.
9. Bate A, Lindquist M, Edwards IR, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54(4):315-321. PubMed doi:10.1007/s002280050466
10. Norén GN, Bate A, Orre R, et al. Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events. Stat Med. 2006;25(21):3740-3757. PubMed doi:10.1002/sim.2473
11. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385-396. PubMed doi:10.2165/00002018-200629050-00003